Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 1, 2003, Pages 36-40

  Wolfe, Frederick ^a   Freundlich, Bruce ^b   Straus, Walter L ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cerebrovascular disease; Osteoarthritis cardiovascular disease; Rheumatoid arthritis; Risk

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; INCOME; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OSTEOARTHRITIS; OUTCOMES RESEARCH; PATIENT INFORMATION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STROKE;

AGED; ARTHRITIS, RHEUMATOID; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OSTEOARTHRITIS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0037225374     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kelly CA, Bourke JP, Malcolm A, Griffiths ID. Chronic pericardial disease in patients with rheumatoid arthritis: A longitudinal study. Q J Med 1990;75:461-70.
2. Thould AK. Constrictive pericarditis in rheumatoid arthritis. Ann Rheum Dis 1986;45:89-94.
3. Cosh JA, Lever JL. Rheumatic diseases and the heart. New York: Springer; 1989.
4. Monson RR, Hall AP. Mortality among arthritics. J Chronic Dis 1976;29:459-67.
5. Mutru O, Laakso M, Isomäki HA, Koota K. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 1989;76:71-7.
6. Wallbergjonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 1997;24:445-51.
7. Myllykangasluosujarvi R, Aho K, Kautiainen H, Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995;22:1065-7.
8. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
9. Mutru O, Koota K, Isomäki HA. Causes of death in autopsied RA patients. Scand J Rheumatol 1976;5:239-40.
10. Isomäki HA, Mutru O, Koota K. Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol 1975;4:205-8.
11. Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and comorbility [editorial]. J Rheumatol 1986;13:841-5.
12. Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: How harmful are corticosteroids? J Rheumatol 1997;24:415-6.
13. Landewe RBM, vandenBorne BEEM, Breedveld FC, Dijkmans BAC. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 2000;355:1616-7.
14. Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol 1996;144:934-42.
15. Reilly PA, Cosh JA, Maddison PJ, Rasker JJ, Silman AJ. Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients. Ann Rheum Dis 1990;49:363-9.
16. Wolfe F, Flowers N, Anderson J. The National Rheumatic Disease Data Bank: case mix and severity characteristics of patients in rheumatological practice. Arthritis Rheum 1998;41 Suppl 9:S132.
17. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis [see comments]. J Rheumatol 2000;27:630-7.
18. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1072-82.
19. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982;9:789-93.
20. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
21. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992;30:473-83.
22. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Brit J Rheumatol 1997;36:551-9.
23. Wolfe F, Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 1997;36:786-93.
24. Wolfe F, Hawley DJ. Evidence of disordered symptom appraisal in fibromyalgia: Increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol 1999;17:297-303.
25. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987;1-278.
26. Statistical Solutions. Solas 2.0. Cork: Statistical Solutions; 2000.
27. Stata Corporation. Stata Statistical Software: Release 6.0. College Station: Stata Corporation; 1999.
28. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology Oxford 2001;40:640-4.
29. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
30. van der Wal AC, Becker AE. Atherosclerotic plaque rupture - pathologic basis of plaque stability and instability. Cardiovasc Res 1999;41:334-44.
31. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
32. Wolfe F, Hawley DJ, Anderson JA. Inflammation as measured by the ESR predicts cardiovascular mortality across all rheumatic disorders: a 25-year prospective study of 5,822 patients. Arthritis Rheum 1999;42 Suppl 9:S299.